Skip to main content

CORRECTION article

Front. Chem., 11 January 2023
Sec. Organic Chemistry
Volume 10 - 2022 | https://doi.org/10.3389/fchem.2022.1131801
This article is part of the Research Topic Small Organic Molecules with Anticancer Activity View all 5 articles

Corrigendum: Pyrazolyl-s-triazine with indole motif as a novel of epidermal growth factor receptor/cyclin-dependent kinase 2 dual inhibitors

This article is a correction to:

  1. Pyrazolyl-s-triazine with indole motif as a novel of epidermal growth factor receptor/cyclin-dependent kinase 2 dual inhibitors

    1. Read original article
Ihab Shawish,Ihab Shawish1,2Mohamed S. NafieMohamed S. Nafie3Assem Barakat Assem Barakat2*Ali AldalbahiAli Aldalbahi2Hessa H. Al-RasheedHessa H. Al-Rasheed2M. AliM. Ali2Walhan AlshaerWalhan Alshaer4Mazhar Al ZoubiMazhar Al Zoubi5Samha Al AyoubiSamha Al Ayoubi1Beatriz G. De La Torre,Beatriz G. De La Torre6,7Fernando Albericio, Fernando Albericio7,8*Ayman El-Faham Ayman El-Faham9*
  • 1Department of Math and Sciences, College of Humanities and Sciences, Prince Sultan University, Riyadh, Saudi Arabia
  • 2Department of Chemistry, College of Science, King Saud University, Riyadh, Saudi Arabia
  • 3Department of Chemistry, Faculty of Science, Suez Canal University, Ismaïlia, Egypt
  • 4Cell Therapy Center, The University of Jordan, Amman, Jordan
  • 5Department of Basic Medical Sciences, Faculty of Sciences, Yarmouk University, Irbid, Jordan
  • 6KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa
  • 7Peptide Science Laboratory, School of Chemistry and Physics, University of KwaZulu-Natal, Durban, South Africa
  • 8CIBER-BBN (Networking Centre on Bioengineering, Biomaterials and Nanomedicine) and Department of Organic Chemistry, University of Barcelona, Barcelona, Spain
  • 9Chemistry Department, Faculty of Science, Alexandria University, Alexandria, Egypt

A Corrigendum on
Pyrazolyl-s-triazine with indole motif as a novel of epidermal growth factor receptor/cyclin-dependent kinase 2 dual inhibitors

by Shawish I, Nafie MS, Barakat A, Aldalbahi A, Al-Rasheed HH, Ali M, Alshaer W, Al Zoubi M, Al Ayoubi S, De la Torre BG, Albericio F and El-Faham A (2022). Front. Chem. 10:1078163. doi: 10.3389/fchem.2022.1078163

In the original article, there was an error in the Affiliation for Samha Al Ayoubi2. Instead of “Samha Al Ayoubi 2”, it should be “Samha Al Ayoubi1”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: pyrazolyl-s-triazine, indole, anticancer profile, EGFR/CDK-2, apoptosis

Citation: Shawish I, Nafie MS, Barakat A, Aldalbahi A, Al-Rasheed HH, Ali M, Alshaer W, Al Zoubi M, Al Ayoubi S, De La Torre BG, Albericio F and El-Faham A (2023) Corrigendum: Pyrazolyl-s-triazine with indole motif as a novel of epidermal growth factor receptor/cyclin-dependent kinase 2 dual inhibitors. Front. Chem. 10:1131801. doi: 10.3389/fchem.2022.1131801

Received: 26 December 2022; Accepted: 30 December 2022;
Published: 11 January 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Shawish, Nafie, Barakat, Aldalbahi, Al-Rasheed, Ali, Alshaer, Al Zoubi, Al Ayoubi, De La Torre, Albericio and El-Faham. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Assem Barakat, YW1iYXJha2F0QGtzdS5lZHUuc2E=; Fernando Albericio, YWxiZXJpY2lvQHVrem4uYWMuemE=; Ayman El-Faham, YXltYW4uZWxmYWhhbUBhbGV4dS5lZHUuZWc=

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.